|
|
Volumn 477, Issue 7363, 2011, Pages 150-152
|
|
Biodefence since 9/11: The price of protection
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTICS;
ANTIBODY;
BIOLOGICAL WEAPON;
BIOSAFETY;
BIOTERRORISM;
DEFENSE INDUSTRY;
DRUG DEVELOPMENT;
FINANCIAL PROVISION;
MEDICINE;
PATHOGEN;
RESEARCH AND DEVELOPMENT;
VACCINATION;
VACCINE;
BIOLOGICAL WARFARE;
HEALTH CARE;
HEALTH CARE COST;
NATIONAL HEALTH ORGANIZATION;
PRIORITY JOURNAL;
SHORT SURVEY;
UNITED STATES;
ANIMALS;
ANTIVIRAL AGENTS;
BIOMEDICAL RESEARCH;
BIOTERRORISM;
BUDGETS;
CYTOSINE;
DISEASE MODELS, ANIMAL;
HUMANS;
MALE;
PHOSPHONIC ACIDS;
SECURITY MEASURES;
SEPTEMBER 11 TERRORIST ATTACKS;
SMALLPOX;
TULAREMIA;
UNITED STATES;
VACCINES;
YOUNG ADULT;
UNITED STATES;
|
|
EID: 80052577453
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/477150a Document Type: Short Survey |
|
Times cited : (19)
|
|
References (0)
|
